Has Bryan Springer, MD received payments from drug or device companies?

Yes. Drug and device makers reported $6,296,237 in general payments to Bryan Springer, MD across 500 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Bryan Springer, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Bryan Springer, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Bryan Springer, MD

Orthopaedic Surgery · Jacksonville, FLNPI 1932182086

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $5,998,984 of the $6,296,237 with a category attached, or 95.3%. Stryker accounts for 92.2% of it on its own, with 14 other manufacturers making up the rest. Among orthopaedic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,296,237in general payments, 2019–2025

Across 500 payments — averaging $12,592 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$5.8M
Osteoremedies, LLC$422K
Convatec Inc.$50K
Signature Orthopaedics USA Corp$9K
Johnson & Johnson$8K
Omnilife Science, Inc$1K
plus $2K from 9 others

$32,421in research payments, 2019–2025

Across 19 payments — averaging $1706.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Stryker$28K
Melinta Therapeutics, LLC$4K

What the payments were for

Royalty or licence$5,998,98495%
Consulting fees$212,1333%
Travel & lodging$75,1571%
Food & beverage$9,9630%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	392	$5,804,596
Osteoremedies, LLC	65	$422,365
Convatec Inc.	21	$49,775
Signature Orthopaedics USA Corp	1	$9,000
Johnson & Johnson(3 entities)	5	$7,914
Omnilife Science, Inc	2	$1,000
Orpyx Medical Technologies Inc.	1	$400
Zimmer Biomet	4	$252
Heron Therapeutics, Inc.	2	$180
Bone Support Inc.	1	$162
Medtronic(2 entities)	2	$155
Medacta USA, Inc.	1	$148
Smith+Nephew	1	$137
Orthalign Inc	1	$120
Davol Inc.	1	$34

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,296,237 in reported general payments places this provider in the 95th percentile of 1,263 orthopaedic surgery providers in Florida.

See all orthopaedic surgery providers in Florida →

Medicare billing

Part B allowed, 2024

$214,419

Medicare patients

276

Services billed

624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Celecoxib	18	$144
Oxycodone Hcl	21	$109
Tramadol Hcl	20	$92
Diclofenac Sodium	11	$85
Meloxicam	15	$53
Amoxicillin	18	$32

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Jacksonville

Jorge AcevedoJacksonville$3.3M
Rahul DeshmukhJacksonville$769K
Andrew CooperClearwater$102M
Richard HynesMelbourne$34.8M
Mark FrankleTemple Terrace$31M
Roy SandersTemple Terrace$19.6M
George HaidukewychOrlando$10M
Robert SantrockFernandina Beach$7.3M
Martin RocheFt. Lauderdale$7.1M
Steven LyonsTampa$6.7M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →